Keywords: banyu, aims, nu-lotan, market, share, japanese, drugmaker
Banyu aims for 30% Nu-lotan market share
Article | 19 January 2004
Japanese drugmaker Banyu (now 99.4% owned by US major Merck & Co; Marketletter October 27, 2003) is planning to increase promotion for its angiotensin ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
